To determine the role of SCD in high AD risk middle-aged individuals, we tested whether APOE genotype modulates the associations of SCD with structural and functional brain measures related to cognitive decline as indexed by brain activation during an fMRI working memory task and white matter integrity, respectively. This evidence concerns the gene APOE and Alzheimer disease.